Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 87Breast Neoplasms 49Prostatic Neoplasms 42Squamous Cell Carcinoma of Head and Neck 34Lung Neoplasms 24Neoplasms 19Stomach Neoplasms 18Head and Neck Neoplasms 17Neoplasm Metastasis 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Urinary Bladder Neoplasms 13Carcinoma, Transitional Cell 11Triple Negative Breast Neoplasms 10Ovarian Neoplasms 8Endometrial Neoplasms 8Carcinoma, Squamous Cell 8Adenocarcinoma 8Non-Muscle Invasive Bladder Neoplasms 7HER2-positive Breast Cancer 7Melanoma 6Carcinoma 6Small Cell Lung Carcinoma 5Prostatic Neoplasms, Castration-Resistant 5Nasopharyngeal Carcinoma 5Esophageal Squamous Cell Carcinoma 5Esophageal Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4

Interventions

Doxorubicin 7pembrolizumab 5Radiotherapy 5Specimen Handling 4Radiation 4Magnetic Resonance Spectroscopy 4palbociclib 3eribulin 3Ifosfamide 3Biopsy 3pazopanib 2brigimadlin 2abemaciclib 2Immunoglobulin G 2zimberelimab 1toripalimab 1talimogene laherparepvec 1silmitasertib 1selinexor 1ribociclib 1peposertib 1pemigatinib 1olaratumab 1olaparib 1mirdametinib 1liposomal doxorubicin 1lenvatinib 1enzalutamide 1durvalumab 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × Docetaxel × 1 year × Clear all
NCT06498648 2026-05-13

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Recruiting
74 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡